1. Clinical & Scientific Overview
Cefuroxime Axetil (TIP-MED-000133, Reference Code [8.5]) is classified under
Antimicrobials — Antibacterial & Antibiotic Agents (Ch 08) as a Second-Generation Oral Cephalosporin Beta-Lactam Antibiotic (Lipophilic Ester Prodrug; WHO 'Watch' Group).
Within the Indian regulatory and compendial framework, it is governed under Schedule H Prescription Drug (To be sold by retail on the prescription of a Registered Medical Practitioner only — Drugs Rules 1945).
Monocef (Aristo), Oframax (Sun Pharma)
Oral Film-Coated Tablets: 125 mg, 250 mg, 500 mg; Paediatric Dry Syrup: 125 mg/5 mL; Parenteral (Cefuroxime Sodium): 750 mg, 1.5 g vials
3. Mechanism of Action & Pharmacodynamics
Second-Generation Oral Cephalosporin Beta-Lactam Antibiotic (Lipophilic Ester Prodrug; WHO 'Watch' Group) acting on target receptor/enzyme pathways in Antimicrobials — Antibacterial & Antibiotic Agents (Ch 08): clinical efficacy is mediated via Second-Generation Oral Cephalosporin Beta-Lactam Antibiotic (Lipophilic Ester Prodrug; WHO 'Watch' Group) for Community-acquired respiratory tract infections (acute bacterial sinusitis, otitis media, AECOPD, pneumonia), uncomplicated urinary tract infections, and skin and soft-tissue infections (unlike cefixime, second-generation cefuroxime retains good activity against methicillin-sensitive Staphylococcus aureus [MSSA] in cellulitis/wound infections and surgical prophylaxis)..
4. Therapeutic Indications & Evidence-Supported Uses
- Community-acquired respiratory tract infections (acute bacterial sinusitis, otitis media, AECOPD, pneumonia), uncomplicated urinary tract infections, and skin and soft-tissue infections (unlike cefixime, second-generation cefuroxime retains good activity against methicillin-sensitive Staphylococcus aureus [MSSA] in cellulitis/wound infections and surgical prophylaxis)
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: General Adult Reference: 250 mg to 500 mg twice daily (every 12 hours) for 5 to 10 days (250 mg BD for mild UTI/bronchitis; 500 mg BD for pneumonia, severe sinusitis, or skin/soft-tissue infections). Follow physician prescription.
Administration & Meal Timing: CRITICAL FOOD RULE: MUST be taken IMMEDIATELY AFTER FOOD! (Cefuroxime axetil is a lipophilic ester prodrug; taking it after a meal increases oral bioavailability from ~37% [fasting] up to ~52–60%!). Swallow the film-coated tablet whole—NEVER crush or chew! | Twice daily (every 12 hours, immediately after breakfast and dinner).
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.
Renal: Strictly renal-function dependent! • CrCl ≥30 mL/min: Standard dose (250–500 mg BD). • CrCl 10–29 mL/min: Administer standard individual dose once every 24 hours. • CrCl <10 mL/min: Administer once every 48 hours (with post-dialysis dose). Hepatic: Safe in liver disease.
Renal: Strictly renal-function dependent! • CrCl ≥30 mL/min: Standard dose (250–500 mg BD). • CrCl 10–29 mL/min: Administer standard individual dose once every 24 hours. • CrCl <10 mL/min: Administer once every 48 hours (with post-dialysis dose). Hepatic: Safe in liver disease.
Renal: Strictly renal-function dependent! • CrCl ≥30 mL/min: Standard dose (250–500 mg BD). • CrCl 10–29 mL/min: Administer standard individual dose once every 24 hours. • CrCl <10 mL/min: Administer once every 48 hours (with post-dialysis dose). Hepatic: Safe in liver disease.
7. Contraindications, Precautions & High-Risk Warnings
- Contraindicated in cephalosporin allergy or severe immediate penicillin hypersensitivity. Caution in history of colitis.
Key Clinical Precautions: Renal: Strictly renal-function dependent! • CrCl ≥30 mL/min: Standard dose (250–500 mg BD). • CrCl 10–29 mL/min: Administer standard individual dose once every 24 hours. • CrCl <10 mL/min: Administer once every 48 hours (with post-dialysis dose). Hepatic: Safe in liver disease.
8. Adverse Effects Profile
- Nausea, diarrhoea, abdominal discomfort, intensely bitter lingering metallic aftertaste if tablet coat is broken, vaginal candidiasis, Jarisch-Herxheimer reaction (when treating Lyme disease).
- Anaphylaxis, angioedema, C. difficile pseudomembranous colitis, SJS/TEN, haemolytic anaemia, cephalosporin-induced encephalopathy in unadjusted renal failure.
- Monitor for severe hypersensitivity, organ toxicity, or dose-limiting adverse events.
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Drugs that Raise Gastric pH (PPIs like Pantoprazole/Omeprazole, H2-blockers like Famotidine, and Antacids) significantly reduce the dissolution and bioavailability of Cefuroxime Axetil! Avoid co-administering antacids within 2 hours, and always take cefuroxime axetil with an acidic/full meal
- Potentiates Warfarin INR
- Probenecid increases cefuroxime AUC by 50%
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: 2 Vital Counter Instructions for Ceftum/Zocef: (1) Always take immediately after breakfast and dinner—taking on an empty stomach wastes almost one-third of the medicine; (2) Swallow the tablet whole without crushing or breaking—crushed cefuroxime axetil is intensely, unbearably bitter (causes immediate gagging/vomiting) and absorbs poorly. If the patient takes an antacid, space it by at least 2 hours.
- Meal & Clock Timing Instruction: CRITICAL FOOD RULE: MUST be taken IMMEDIATELY AFTER FOOD! (Cefuroxime axetil is a lipophilic ester prodrug; taking it after a meal increases oral bioavailability from ~37% [fasting] up to ~52–60%!). Swallow the film-coated tablet whole—NEVER crush or chew! (Twice daily (every 12 hours, immediately after breakfast and dinner).)
- Missed Dose Protocol: Take with food as soon as remembered unless close to next scheduled dose.
- Geriatric Dispensing Pearl: In elderly CGHS patients taking daily Pantoprazole/Omeprazole, taking Cefuroxime Axetil on an empty stomach leads to high rates of treatment failure due to high gastric pH—insist on taking it with a full meal and adjust to once daily if CrCl <30 mL/min.
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Oral Film-Coated Tablets: 125 mg, 250 mg, 500 mg; Paediatric Dry Syrup: 125 mg/5 mL; Parenteral (Cefuroxime Sodium): 750 mg, 1.5 g vials
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) • Ch 08 [8.5] (p. 95)
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: HANDBOOK_SOURCE_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [8.20] Clarithromycin & Erythromycin — Macrolide 50S Ribosomal Protein Synthesis Inhibitors — Potent CYP
- [8.21] Clindamycin Hydrochloride / Phosphate — Lincosamide 50S Ribosomal Inhibitor & Bacterial Toxin Suppressor
- [8.22] Linezolid — Oxazolidinone 50S Ribosomal Initiation Complex Inhibitor — ICMR '
- [8.23] Amikacin Sulfate & Gentamicin Sulfate — Aminoglycoside 30S Ribosomal Bactericidal Antibiotics (Schedule H